Page 51 - Pharma

Teva's $40 bn offer to buy Mylan could transform generics space: GlobalData

If the deal goes ahead, the combined company would create a global generics giant with nearly $30 billion in revenue

Teva proposes to buy rival Mylan for $40 bn

The combined Teva and Mylan would have pro forma 2014 revenues of approximately $ 30 billion and pro forma 2014 EBITDA of approximately $ 9 billion

Claris receives approval for fluconazole injection in 50 ml PVC bags in US

The Ahmedabad-based firm will be the only company offering fluconazole injection USP in 50 ml PVC bags in the US

Claris ends litigation row with Fresenius Kabi over propofol injection

For this, the company has reached a settlement and license agreement, ending all pending litigation with Fresenius Kabi USA

Lupin launches antibiotic drug Zaxine in Canada

The drug was launched under a strategic licensing agreement with the North Carolina based gastrointestinal (GI) specialty company Salix Pharmaceuticals

Aurobindo Pharma receives US FDA nod for antibiotic Cefixime oral suspension

The product has an estimated market size of $ 123 million for the twelve months ending February 2015, according to IMS

Udit Batra to head Merck's combined life science business

Appointment of Udit Batra, who has been CEO and president of Merck Millipore since 2014, will take effect following successful completion of Sigma-Aldrich acquisition expected for mid-2015

Sun Pharma ties up with Israeli institute Technion for oncology drug research

This agreement aims to set up a joint project that can potentially lead to the development of novel anti-cancer drugs

Japan's Tosoh acquires in-vitro diagnostics firm Lilac Medicare

With this move, Tosoh aims to increase its share in the growing Indian market by using its own immunological and diabetes diagnostic analysers

Aurobindo Pharma divests stake in Australian subsidiary to Eris Pharma

This divestment is in line with Aurobindo Pharma's strategy to focus on US, EU and key emerging markets

Cipla buys pharma distributor Duomed in Brazil

The acquisition is part of company's front-end strategy and will expedite its product registrations in Brazil

Govt plans to set up medical devices parks to boost indigenous production

First such park expected to be built in Gujarat

Aurobindo Pharma receives USFDA nod for anaesthesia drug

The company has received approval for atracurium besylate injections, which are indicated as an adjunct to general anaesthesia for facilitating endotracheal intubation

Ipca Labs starts open offer for Krebs Biochemicals

If Ipca gets the management control of Krebs Bio, it is expected to bolster its capabilities with the knowhow of Krebs in bio-fermentation & its two US FDA-approved facilities

Biocon receives approval for insulin glargine in in Mexico

Galactus by PiSA, Biocon's partner, is the first insulin glargine to be approved in Mexico as per the biocomparable approvals pathway defined in 2012

Suven completes SAD studies in phase 1 clinical trial for CNS drug

The company has initiated multiple ascending dose (MAD) studies in phase 1 clinical trial for their investigational compound SUVN-G3031

Caplin Point inks license pact with UK-based Cycle Pharmaceuticals

Under the pact, Caplin Point will be responsible for developing and manufacturing identified liquid injectable products, while Cycle Pharmaceuticals commercialise the same in the US

Corbion acquires Archer Daniels Midland's lactic acid business

This transaction includes the sales and delivery of lactic acid, sodium lactate, and potassium lactate products

Merck & Pfizer tie up for co-promoting cancer drug Xalkori

In the second and third quarters of 2015, Merck and Pfizer will begin co-promoting Xalkori in the US, Canada, Japan and five European Union countries

CCEA approves FII investments in Aurobindo Pharma & Glenmark

QIBs to infuse fresh equity of upto 7% amounting to about Rs 2165 cr in Aurobindo, while Glenmark has increased the foreign investment limit by FIIs from 35.07% to 49%